GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's ...

Experts made the discovery after analysing hours of YouTube footage of celebrities with the disease - and it paves the way ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

For the Cook family, supporting Cure Parkinson's is a personal cause as Joyce's son, Will, was close friends with the late Tom Isaacs, one of the founders of the charity. Will is also the former CEO ...

AC Immune (ACIU) stock shot up 20% Thursday after the company reported positive data from a Phase 2 study of its drug ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...

The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...

AC Immune SA (ACIU) has released an update. AC Immune SA announced promising interim results from its Phase 2 trial of the ACI-7104.056 ...

Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...

The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.